Healthcare Industry News:  Magnetic Resonance Imaging 

Devices Radiology Cardiology Product Launch

 News Release - December 7, 2015

Arterys Partners With GE Healthcare To Launch Transformative Cardiac Medical Imaging Platform

Arterys™ System Extends MRI into New Dimension to Measure Blood Flow, Enabling Accurate Diagnosis Faster, Cheaper with its Machine Learning Analytics Platform

Launched at Radiology Society of North America through GE Healthcare's ViosWorks*

Company Raises $7 Million in Series A Financing to Expand Commercialization Efforts

SAN FRANCISCO, Dec. 7, 2015 -- (Healthcare Sales & Marketing Network) -- Arterys Inc., a privately-held medical imaging company providing a SaaS analytics platform that integrates cloud computation and machine learning, today announced the launch of the Arterys™ System, a revolutionary intelligence platform designed to significantly enhance standard medical imaging.

Its first application is in the cardiovascular space, enabling clinical visualization and accurate quantification of blood flow inside the human body. The seven-dimensional data (three in space, one in time, three in velocity direction) input quickly and easily to improve diagnoses in cardiac medicine.

The Arterys™ system was launched at the 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America in Chicago, Illinois, as part of GE Healthcare's (GE) ViosWorks*, a new comprehensive cardiac solution that reduces Magnetic Resonance Imaging (MRI) assessment to a fraction of the time of conventional cardiac scans. ViosWorks will provide 3D cardiac anatomy, function, and flow in one free-breathing, 10-minute scan with cloud-based, real-time processing of images at resolutions previously unattainable.

"We are excited to collaborate with Arterys and introduce this innovative cardiac MR solution that can capture seven-dimensional viewing capabilities of the heart," said Ioannis Panagiotelis, chief marketing officer, Global MR at GE Healthcare. "With cardiovascular disease as the leading cause of death in the world, we believe that this cloud-enabled technology will help us to provide value not only for clinicians by delivering advanced visualization and quantification of cardiovascular function, but also help simplify cardiovascular examinations and address significant patient needs in cardiovascular disease."

In November 2015, Arterys and GE Healthcare entered into a partnership to include the Arterys™ System in new GE Healthcare MRI machines. Financial terms of the agreement were not disclosed.

"We are extremely pleased to announce our partnership with GE Healthcare in conjunction with the launch of our first cardiac care solution, the first self-learning system of its kind to visualize and quantify blood flow leveraging a standard MRI machine," said Fabien Beckers, Ph.D., founder and CEO of Arterys. "This pivotal milestone for the company is directly in line with our vision to transform medical imaging by bringing automatic quantitative data and deep learning to healthcare applications through a GPU smart cloud platform that can be applied to many areas of medical imaging including neurology and oncology."

In addition to the launch of the Arterys™ System, the company completed a $7 million Series A financing led by Emergent Medical Partners, including participation from Norwich Ventures, AME Cloud Ventures, Morado Ventures and Asset Management Ventures.

"This financing will allow us to expand our efforts in machine and deep learning for medical imaging, validate our innovative approach, and bring our imaging platform to new medical applications," continued Dr. Beckers. "We are extremely pleased to welcome thought leaders in the field of machine learning and medical imaging as part of this investment round."

*Not yet commercially available

About the Arterys™ Platform

Arterys™ is a cloud-based medical imaging, machine learning platform designed to deliver ultra-fast visualization and quantification with automatic analysis. The system received its CE Mark and market clearance from the U.S. Food and Drug Administration in March 2014. The Arterys platform is currently being used for research in several leading hospitals in the United States and Europe. To view videos of the Arterys™ system, please click here and here.

About Arterys Inc.

Arterys Inc. opens medical imaging to the power of the cloud. Arterys developed 4D Flow technology, which generates precise measurements of blood flow noninvasively and non-radiatively anywhere in the body. The company's medical imaging SaaS analytics platform combines the best of cloud computation and machine learning to improve diagnostic and therapeutic decisions. This is the first solution to enable physicians to visualize and analyze blood flow inside the heart in 3D with automatic, interactive reporting. Arterys plans to take its ultra-fast visualization, unlimited file size, real-time automated quantification, peer-based learning algorithms and time savings to other medical applications. By making imaging diagnostics quantitative, intelligent and available, Arterys seeks to improve the lives of millions of patients. For more information, please visit Follow Arterys on Twitter at @ArterysInc at

Source: Arterys

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.